← 產業報告目錄

Cell Isolation Market/Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-05-22頁數 525報告編號 BT2435

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The cell isolation market is expected to reach USD 7.97 billion in 2031 from USD 4.39 billion in 2026, at a CAGR of 12.7% during the forecast period. The market is primarily driven by the expansion of cell and gene therapy workflows, rising demand for immune cell isolation, growing adoption of single-cell analysis, and increasing use of automated and closed isolation systems. Technologies such as centrifugation-based isolation, magnetic-activated cell separation, fluorescence-activated cell sorting, microfluidic isolation, and filtration-based separation enable the enrichment and purification of specific cell populations, including immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells. These technologies support applications across drug discovery, immunology research, cancer biology, regenerative medicine, biomarker discovery, and clinical research. In addition, the growing demand for GMP-grade cell isolation products is driving adoption of validated kits, magnetic beads, single-use consumables, and closed-system platforms across clinical and manufacturing workflows. However, market growth continues to be challenged by the high cost of instruments and consumables, loss of cell viability and recovery during isolation, and difficulties in scaling research workflows to GMP manufacturing while balancing purity, yield, viability, and cost. “The consumables segment is expected to grow at the highest CAGR during the forecast period” The consumables segment is projected to grow at the highest CAGR in the cell isolation market, driven by the recurring use of magnetic beads, antibody-based isolation kits, density gradient media, buffers, cell strainers, columns, and single-use kits across research and clinical workflows. These products are widely used for immune cell isolation, stem cell enrichment, isolation of circulating tumor cells, primary cell separation, and sample preparation for downstream analysis. The growing use of cell isolation in cell and gene therapy development, single-cell analysis, immunology research, and cancer biology is increasing demand for high-purity, validated, and application-specific consumables. “Human cells segment holds the largest share of the market” The human cells segment accounts for the largest share of the cell isolation market, driven by the increasing use of human-derived immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells in drug discovery, translational research, regenerative medicine, and clinical applications. Human cell isolation plays a critical role in immune profiling, biomarker discovery, cancer research, personalized medicine, and cell and gene therapy workflows. The growing demand for biologically relevant human cell models, along with the rising adoption of single-cell analysis and GMP-compatible cell processing, continues to strengthen this segment's position. “The US is expected to grow at the highest CAGR during the forecast period” The US is expected to grow at the highest CAGR in the cell isolation market due to its strong presence of leading life science companies, advanced biomedical research infrastructure, and high adoption of cell separation technologies across research and clinical settings. The rising use of cell isolation in cell and gene therapy development, immuno-oncology, stem cell research, single-cell analysis, and biomarker discovery is a key factor driving market growth. Technologies such as magnetic-activated cell separation, fluorescence-activated cell sorting, centrifugation-based isolation, and automated closed-system platforms are widely used across pharmaceutical companies, biotechnology firms, academic institutes, and clinical laboratories, further supporting demand. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side – 70% and Demand Side– 30% • By Designation: Managers – 45%, CXOs and Directors – 30%, and Executives – 25% • By Region: North America – 40%, Europe – 25%, Asia Pacific – 25%, Latin America – 5%, the Middle East & Africa – 5% Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), Corning Incorporated (US), Lonza (Switzerland), Bio-Techne (US), Terumo Corporation (Japan), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), GenScript (US), Sony Group Corporation (Japan), Alfa Laval (Sweden), Promega Corporation (US), Cell Signaling Technology, Inc. (US), MiCareo Inc. (Taiwan), Applied Cells, Inc. (US), STEMCELL Technologies (Canada), Creative Bioarray (US), Proteintech Group, Inc. (US), MagBio Genomics, Inc. (US), Akadeum Life Sciences (US), pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG (Germany), and Invent Biotechnologies, Inc. (US) are some of the key companies offering cell isolation products. Research Coverage This research report categorizes the cell isolation market by product (consumables [reagents & kits {cell isolation reagents & kits, tissue dissociation reagents & kits, other reagents & kits}, media and sera, beads {magnetic beads, fluorescent beads}, and disposables] and instruments [centrifuges, cell sorters, magnetic-activated cell separator systems, filtration systems, and other instruments]), cell type (human cells [differentiated cells, stem cells] and animal cells), cell source (blood & blood-derived samples, adipose tissue, bone marrow, cord blood/embryonic stem cells, and other cell sources), technique (centrifugation-based cell isolation, surface marker-based cell isolation, filtration-based cell isolation, and microfluidics & label-free cell isolation), application (research applications [biomolecule isolation, cancer research, stem cell research, regenerative medicine, and other research applications], drug discovery and development, in vitro diagnostics, CGT manufacturing), end user (pharmaceutical & biotechnology companies, academic & research institutes, biopharmaceutical companies, hospitals & diagnostic laboratories, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The report’s scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the cell isolation market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product portfolios, key strategies, new product launches, acquisitions, and recent developments in the cell isolation market. This report also includes a competitive analysis of emerging startups in the cell isolation industry ecosystem. Key Benefits of Buying the Report The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (expansion of cell and gene therapy workflows, rising demand for immune cell isolation, growing adoption of single-cell analysis, shift toward automated and closed isolation systems), restraints (high cost of instruments and consumables, loss of cell viability and recovery during isolation), opportunities (growing demand for GMP-grade cell isolation products, adoption of microfluidic and label-free isolation technologies), and challenges (scaling research workflows to GMP manufacturing, balancing purity, yield, viability, and cost) influencing the market growth • Product Development/Innovation: Detailed insights into newly launched products and innovations in the cell isolation market • Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players, Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), and Corning Incorporated (US), among others, for the cell isolation market
目錄 Table of Contents
1 INTRODUCTION 46 1.1 STUDY OBJECTIVES 46 1.2 MARKET DEFINITION 46 1.3 STUDY SCOPE 46 1.3.1 MARKET SEGMENTATION & REGIONS COVERED 47 1.3.2 INCLUSIONS & EXCLUSIONS 48 1.3.3 YEARS CONSIDERED 49 1.3.4 CURRENCY CONSIDERED 49 1.4 STAKEHOLDERS 49 1.5 SUMMARY OF CHANGES 50 2 EXECUTIVE SUMMARY 51 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 51 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 52 2.3 DISRUPTIVE TRENDS IN CELL ISOLATION MARKET 53 2.4 HIGH-GROWTH SEGMENTS 54 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 55 3 PREMIUM INSIGHTS 56 3.1 CELL ISOLATION MARKET OVERVIEW 56 3.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT AND COUNTRY 57 3.3 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58 3.4 CELL ISOLATION MARKET SHARE, BY PRODUCT, 2026 VS. 2031 (%) 58 4 MARKET OVERVIEW 59 4.1 INTRODUCTION 59 4.2 MARKET DYNAMICS 60 4.2.1 DRIVERS 61 4.2.1.1 Expansion of cell and gene therapy workflows 61 4.2.1.2 Rising demand for immune cell isolation 61 4.2.1.3 Growing adoption of single-cell analysis 62 4.2.1.4 Shift toward automated and closed isolation systems 62 4.2.2 RESTRAINTS 62 4.2.2.1 High cost of instruments and consumables 62 4.2.2.2 Loss of cell viability and recovery during isolation 63 4.2.3 OPPORTUNITIES 63 4.2.3.1 Growing demand for GMP-grade cell isolation products 63 4.2.3.2 Adoption of microfluidic and label-free isolation technologies 64   4.2.4 CHALLENGES 64 4.2.4.1 Scaling research workflows to GMP manufacturing 64 4.2.4.2 Balancing purity, yield, viability, and cost 65 4.3 UNMET NEEDS & WHITE SPACES 65 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 66 4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS 66 5 INDUSTRY TRENDS 68 5.1 PORTER’S FIVE FORCES ANALYSIS 68 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 69 5.1.2 BARGAINING POWER OF SUPPLIERS 69 5.1.3 BARGAINING POWER OF BUYERS 70 5.1.4 THREAT OF SUBSTITUTES 70 5.1.5 THREAT OF NEW ENTRANTS 70 5.2 MACROECONOMIC OUTLOOK 70 5.2.1 INTRODUCTION 70 5.2.2 GDP TRENDS & FORECAST 71 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 71 5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY 71 5.3 VALUE CHAIN ANALYSIS 72 5.4 ECOSYSTEM ANALYSIS 73 5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 75 5.5 PRICING ANALYSIS 75 5.5.1 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023–2025 76 5.5.2 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023–2025 77 5.5.3 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023–2025 78 5.5.4 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023–2025 78 5.6 TRADE ANALYSIS 79 5.6.1 IMPORT SCENARIO (HS CODE 3822.00) 80 5.6.2 EXPORT SCENARIO (HS CODE 3822.00) 80 5.7 KEY CONFERENCES & EVENTS, 2026–2027 81 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 5.9 INVESTMENT & FUNDING SCENARIO 82 5.10 CASE STUDY ANALYSIS 84 5.10.1 MICROFLUIDIC CELL SORTING IMPROVES CAR-T STARTING MATERIAL QUALITY 84 5.10.2 CLOSED-SYSTEM CELL ENRICHMENT SUPPORTS NK CELL MANUFACTURING 84 5.10.3 MICROFLUIDIC ISOLATION ENHANCES CTC RECOVERY IN PANCREATIC CANCER 84   5.11 IMPACT OF 2025 US TARIFFS ON CELL ISOLATION MARKET 85 5.11.1 INTRODUCTION 85 5.11.2 KEY TARIFF RATES 85 5.11.3 PRICE IMPACT ANALYSIS 86 5.11.4 IMPACT ON COUNTRY/REGION 87 5.11.4.1 US 87 5.11.4.2 Europe 87 5.11.4.3 Asia Pacific 88 5.11.5 IMPACT ON END-USE INDUSTRIES 88 5.11.5.1 Pharmaceutical & biotechnology companies 88 5.11.5.2 Academic & research institutes 88 5.11.5.3 Hospitals & diagnostic laboratories 89 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 90 6.1 TECHNOLOGY ANALYSIS 90 6.1.1 KEY TECHNOLOGIES 90 6.1.1.1 Centrifugation-based techniques 90 6.1.1.2 Magnetic cell isolation 90 6.1.1.3 Fluorescence-activated cell sorting 91 6.1.1.4 Acoustofluidic cell isolation 91 6.1.1.5 Filtration & size-based cell isolation 91 6.1.2 COMPLEMENTARY TECHNOLOGIES 92 6.1.2.1 Mass cytometry 92 6.1.2.2 Cell imaging technologies 92 6.1.2.3 AI-enabled image-based sorting 92 6.1.3 ADJACENT TECHNOLOGIES 93 6.1.3.1 Single-cell sequencing 93 6.1.3.2 CRISPR & gene editing 93 6.1.3.3 3D cell culture & organoids 93 6.2 TECHNOLOGY ROADMAP 94 6.3 PATENT ANALYSIS 94 6.3.1 METHODOLOGY 94 6.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 94 6.3.3 LIST OF KEY PATENTS 95 6.4 FUTURE APPLICATIONS 96 6.5 IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET 97 6.5.1 TOP USE CASES & MARKET POTENTIAL 98 6.5.2 BEST PRACTICES IN AI-ENABLED CELL ISOLATION WORKFLOWS 99 6.5.3 CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET 99 6.5.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 99 6.5.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES 100 7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 102 7.1 DECISION-MAKING PROCESS 102 7.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 102 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 102 7.2.2 KEY BUYING CRITERIA, BY END USER 103 7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 104 7.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 105 8 SUSTAINABILITY & REGULATORY LANDSCAPE 106 8.1 REGIONAL REGULATIONS & COMPLIANCE 106 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106 8.1.2 INDUSTRY STANDARDS 108 8.1.2.1 North America 109 8.1.2.2 Europe 109 8.1.2.3 Asia Pacific 110 8.1.2.4 Rest of the world 110 8.2 SUSTAINABILITY INITIATIVES 111 8.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 111 8.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 112 9 CELL ISOLATION MARKET, BY PRODUCT 115 9.1 INTRODUCTION 116 9.2 CONSUMABLES 116 9.2.1 REAGENTS & KITS 120 9.2.1.1 Cell isolation reagents & kits 124 9.2.1.1.1 Expansion of downstream single-cell genomics to drive market 124 9.2.1.2 Tissue dissociation reagents & kits 127 9.2.1.2.1 Influx of solid tumor oncology profiling and primary cell culture derivations to drive growth 127 9.2.1.3 Other reagents & kits 131 9.2.2 MEDIA & SERA 134 9.2.2.1 Rising focus on viable, reproducible, and clinically compatible isolated cell workflows to fuel market 134 9.2.3 BEADS 137 9.2.3.1 Growing demand for beads in T-cell and stem cell isolation to drive market growth 137 9.2.4 DISPOSABLES 141 9.2.4.1 Growing government investments in research to aid market growth 141   9.3 INSTRUMENTS 144 9.3.1 CENTRIFUGES 148 9.3.1.1 Growing use in pharma-biotech industry to boost market 148 9.3.2 CELL SORTERS 152 9.3.2.1 Rise in cell-based research initiatives to augment growth 152 9.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS 155 9.3.3.1 Booming use in research for T-cell and stem cell isolation to drive market 155 9.3.4 FILTRATION SYSTEMS 159 9.3.4.1 Rising need to ensure Good Manufacturing Practice standards and regulations to boost market 159 9.3.5 OTHER INSTRUMENTS 163 10 CELL ISOLATION MARKET, BY CELL TYPE 166 10.1 INTRODUCTION 167 10.2 HUMAN CELLS 167 10.2.1 DIFFERENTIATED CELLS 171 10.2.1.1 Rising use of mature human cell populations in translational research and drug development to fuel growth 171 10.2.2 STEM CELLS 174 10.2.2.1 Rise in grants and funding for stem cell research to drive market 174 10.3 ANIMAL CELLS 178 10.3.1 GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH 178 11 CELL ISOLATION MARKET, BY CELL SOURCE 182 11.1 INTRODUCTION 183 11.2 BLOOD & BLOOD-DERIVED SAMPLES 183 11.2.1 GROWING USE OF IMMUNE CELL ISOLATION FROM BLOOD-DERIVED SAMPLES TO DRIVE MARKET 183 11.3 ADIPOSE TISSUE 187 11.3.1 INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET 187 11.4 BONE MARROW 190 11.4.1 GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH 190 11.5 CORD BLOOD/EMBRYONIC STEM CELLS 194 11.5.1 GROWING USE OF STEM AND PROGENITOR CELL ISOLATION IN REGENERATIVE MEDICINE AND CELL THERAPY RESEARCH TO SUPPORT MARKET GROWTH 194 11.6 OTHER CELL SOURCES 197   12 CELL ISOLATION MARKET, BY TECHNIQUE 201 12.1 INTRODUCTION 202 12.2 CENTRIFUGATION-BASED CELL ISOLATION 202 12.2.1 RISING DEMAND FOR SCALABLE, AUTOMATED, AND CLOSED CELL PREPARATION WORKFLOWS TO FUEL MARKET 202 12.3 SURFACE MARKER-BASED CELL ISOLATION 206 12.3.1 GROWING NEED FOR MARKER-SPECIFIC AND HIGH-PURITY CELL POPULATIONS TO PROPEL MARKET 206 12.4 FILTRATION-BASED CELL ISOLATION 209 12.4.1 NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET 209 12.5 MICROFLUIDICS & LABEL-FREE CELL ISOLATION 213 12.5.1 HIGH DEMAND FOR ONCOLOGY RESEARCH TO SUPPORT SEGMENTAL GROWTH 213 13 CELL ISOLATION MARKET, BY APPLICATION 216 13.1 INTRODUCTION 217 13.2 RESEARCH APPLICATIONS 217 13.2.1 BIOMOLECULE ISOLATION 221 13.2.1.1 Increasing demand for biopharmaceutical products to fuel market 221 13.2.2 CANCER RESEARCH 225 13.2.2.1 Precision oncology and rare tumor cell analysis to drive market 225 13.2.3 STEM CELL RESEARCH 228 13.2.3.1 Rising grants and funding for stem cell research to augment growth 228 13.2.4 REGENERATIVE MEDICINE 232 13.2.4.1 Expanding stem cell and translational therapy research to support market 232 13.2.5 OTHER RESEARCH APPLICATIONS 235 13.3 DRUG DISCOVERY & DEVELOPMENT 239 13.3.1 RISING ADOPTION OF CELL-BASED DRUG DISCOVERY AND PRECISION THERAPEUTICS TO PROPEL MARKET 239 13.4 IN VITRO DIAGNOSTICS 242 13.4.1 RISING ADOPTION OF LIQUID BIOPSY AND PRECISION DIAGNOSTICS TO PROPEL MARKET 242 13.5 CGT MANUFACTURING 246 13.5.1 EXPANSION OF GMP-COMPLIANT CGT MANUFACTURING CAPACITY TO PROPEL MARKET 246   14 CELL ISOLATION MARKET, BY END USER 250 14.1 INTRODUCTION 251 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 251 14.2.1 INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH 251 14.3 ACADEMIC & RESEARCH INSTITUTES 255 14.3.1 HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT 255 14.4 HOSPITALS & DIAGNOSTIC LABORATORIES 258 14.4.1 RISING DEMAND FOR ENRICHED CLINICAL CELL POPULATIONS IN ONCOLOGY AND HEMATOLOGY DIAGNOSTICS TO DRIVE MARKET 258 14.5 OTHER END USERS 262 15 CELL ISOLATION MARKET, BY REGION 265 15.1 INTRODUCTION 266 15.2 NORTH AMERICA 266 15.2.1 US 272 15.2.1.1 Strong biopharma R&D and advanced cell sorting adoption to drive market 272 15.2.2 CANADA 276 15.2.2.1 Expanding cell therapy manufacturing and regenerative medicine research to propel market 276 15.3 EUROPE 281 15.3.1 GERMANY 286 15.3.1.1 Strong cell & gene therapy translation and GMP-ready automated cell processing to aid market growth 286 15.3.2 UK 291 15.3.2.1 Expanding advanced therapy infrastructure and GMP-compatible cell processing workflows to drive market 291 15.3.3 FRANCE 296 15.3.3.1 Expanding biotherapy research and cell & gene therapy infrastructure to drive market 296 15.3.4 ITALY 301 15.3.4.1 Expanding advanced therapy trials and ex vivo gene therapy capabilities to drive market 301 15.3.5 SPAIN 306 15.3.5.1 Hospital-based CAR-T manufacturing and GMP-compatible cell processing workflows to aid growth 306 15.3.6 REST OF EUROPE 311   15.4 ASIA PACIFIC 316 15.4.1 CHINA 322 15.4.1.1 Expanding cell therapy pipelines and regenerative medicine commercialization to boost market 322 15.4.2 JAPAN 327 15.4.2.1 iPSC research leadership, regenerative medicine commercialization, and domestic cell therapy manufacturing expansion to drive market growth 327 15.4.3 INDIA 332 15.4.3.1 BioE3-led biomanufacturing and translational research expansion propel market 332 15.4.4 AUSTRALIA 337 15.4.4.1 Hospital-linked GMP cell therapy capacity, regenerative medicine trials, and translational research infrastructure to fuel market 337 15.4.5 SOUTH KOREA 342 15.4.5.1 Bioprocessing infrastructure expansion and regenerative medicine focus to support market growth 342 15.4.6 REST OF ASIA PACIFIC 347 15.5 LATIN AMERICA 352 15.5.1 BRAZIL 357 15.5.1.1 Advanced therapy regulation and oncology research strength to drive market 357 15.5.2 MEXICO 362 15.5.2.1 Regulatory strengthening and pharmaceutical infrastructure growth to support the market 362 15.5.3 REST OF LATIN AMERICA 367 15.6 MIDDLE EAST 372 15.6.1 GCC COUNTRIES 378 15.6.1.1 Saudi Arabia 383 15.6.1.1.1 Local advanced therapy manufacturing and precision medicine investment to boost market 383 15.6.1.2 UAE 388 15.6.1.2.1 Stem cell research infrastructure and regenerative medicine standards to aid market growth 388 15.6.1.3 Rest of GCC Countries 393 15.6.2 REST OF MIDDLE EAST 398 15.7 AFRICA 403 15.7.1 POPULATION-SPECIFIC ONCOLOGY RESEARCH AND INFECTIOUS DISEASE STUDIES TO PROPEL MARKET 403   16 COMPETITIVE LANDSCAPE 409 16.1 OVERVIEW 409 16.2 KEY PLAYER STRATEGY/RIGHT TO WIN, JANUARY 2023–APRIL 2026 409 16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023–APRIL 2026 409 16.3 REVENUE ANALYSIS, 2021–2025 411 16.4 MARKET SHARE ANALYSIS, 2025 412 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 414 16.5.1 STARS 414 16.5.2 EMERGING LEADERS 414 16.5.3 PERVASIVE PLAYERS 414 16.5.4 PARTICIPANTS 415 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 416 16.5.5.1 Company footprint 416 16.5.5.2 Region footprint 417 16.5.5.3 Product footprint 418 16.5.5.4 Cell type footprint 419 16.5.5.5 End-user footprint 420 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 421 16.6.1 PROGRESSIVE COMPANIES 421 16.6.2 RESPONSIVE COMPANIES 421 16.6.3 DYNAMIC COMPANIES 421 16.6.4 STARTING BLOCKS 421 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 423 16.6.5.1 Detailed list of key startup/SME players 423 16.6.5.2 Competitive benchmarking of startups/SMEs 424 16.7 COMPANY VALUATION & FINANCIAL METRICS 425 16.7.1 COMPANY VALUATION 425 16.7.2 FINANCIAL METRICS 425 16.8 BRAND/PRODUCT COMPARISON 426 16.9 COMPETITIVE SCENARIO 427 16.9.1 PRODUCT LAUNCHES 427 16.9.2 DEALS 428 16.9.3 EXPANSIONS 429   17 COMPANY PROFILES 430 17.1 KEY PLAYERS 430 17.1.1 DANAHER CORPORATION 430 17.1.1.1 Business overview 430 17.1.1.2 Products offered 431 17.1.1.3 Recent developments 432 17.1.1.3.1 Deals 432 17.1.1.4 MnM view 433 17.1.1.4.1 Key strengths 433 17.1.1.4.2 Strategic choices 433 17.1.1.4.3 Weaknesses & competitive threats 433 17.1.2 MERCK KGAA 434 17.1.2.1 Business overview 434 17.1.2.2 Products offered 435 17.1.2.3 Recent developments 436 17.1.2.3.1 Deals 436 17.1.2.3.2 Expansions 436 17.1.2.4 MnM view 437 17.1.2.4.1 Key strengths 437 17.1.2.4.2 Strategic choices 437 17.1.2.4.3 Weaknesses & competitive threats 437 17.1.3 THERMO FISHER SCIENTIFIC INC. 438 17.1.3.1 Business overview 438 17.1.3.2 Products offered 439 17.1.3.3 Recent developments 443 17.1.3.3.1 Product launches 443 17.1.3.3.2 Deals 444 17.1.3.3.3 Expansions 445 17.1.3.4 MnM view 446 17.1.3.4.1 Key strengths 446 17.1.3.4.2 Strategic choices 446 17.1.3.4.3 Weaknesses & competitive threats 446 17.1.4 BECTON, DICKINSON AND COMPANY 447 17.1.4.1 Business overview 447 17.1.4.2 Products offered 448 17.1.4.3 Recent developments 451 17.1.4.3.1 Product launches 451 17.1.4.3.2 Deals 451 17.1.4.4 MnM view 451 17.1.4.4.1 Key strengths 451 17.1.4.4.2 Strategic choices 452 17.1.4.4.3 Weaknesses & competitive threats 452 17.1.5 AGILENT TECHNOLOGIES, INC. 453 17.1.5.1 Business overview 453 17.1.5.2 Products offered 454 17.1.5.3 Recent developments 455 17.1.5.3.1 Deals 455 17.1.5.4 MnM view 455 17.1.5.4.1 Key strengths 455 17.1.5.4.2 Strategic choices 455 17.1.5.4.3 Weaknesses & competitive threats 455 17.1.6 SARTORIUS AG 456 17.1.6.1 Business overview 456 17.1.6.2 Products offered 457 17.1.7 BIO-RAD LABORATORIES, INC. 459 17.1.7.1 Business overview 459 17.1.7.2 Products offered 460 17.1.7.3 Recent developments 461 17.1.7.3.1 Product launches 461 17.1.8 QIAGEN 462 17.1.8.1 Business overview 462 17.1.8.2 Products offered 463 17.1.8.3 Recent developments 464 17.1.8.3.1 Deals 464 17.1.9 F. HOFFMANN-LA ROCHE LTD. 465 17.1.9.1 Business overview 465 17.1.9.2 Products offered 466 17.1.9.3 Recent developments 467 17.1.9.3.1 Expansions 467 17.1.10 REVVITY 468 17.1.10.1 Business overview 468 17.1.10.2 Products offered 469 17.1.11 CORNING INCORPORATED 472 17.1.11.1 Business overview 472 17.1.11.2 Products offered 473 17.1.12 LONZA 475 17.1.12.1 Business overview 475 17.1.12.2 Products offered 476 17.1.13 BIO-TECHNE 477 17.1.13.1 Business overview 477 17.1.13.2 Products offered 478 17.1.14 TERUMO CORPORATION 480 17.1.14.1 Business overview 480 17.1.14.2 Products offered 481 17.1.15 MILTENYI BIOTEC 482 17.1.15.1 Business overview 482 17.1.15.2 Products offered 482 17.1.16 TAKARA BIO INC. 484 17.1.16.1 Business overview 484 17.1.16.2 Products offered 485 17.1.17 GENSCRIPT 487 17.1.17.1 Business overview 487 17.1.17.2 Products offered 488 17.1.17.3 Recent developments 489 17.1.17.3.1 Deals 489 17.1.18 SONY CORPORATION 490 17.1.18.1 Business overview 490 17.1.18.2 Products offered 491 17.1.19 ALFA LAVAL 492 17.1.19.1 Business overview 492 17.1.19.2 Products offered 493 17.1.19.3 Recent developments 494 17.1.19.3.1 Product launches 494 17.1.19.3.2 Deals 495 17.2 OTHER PLAYERS 496 17.2.1 PROMEGA CORPORATION 496 17.2.2 CELL SIGNALING TECHNOLOGY, INC. 497 17.2.3 MICAREO INC. 497 17.2.4 APPLIED CELLS, INC. 498 17.2.5 STEMCELL TECHNOLOGIES 499 17.2.6 CREATIVE BIOARRAY 500 17.2.7 PROTEINTECH GROUP, INC. 500 17.2.8 MAGBIO GENOMICS, INC. 501 17.2.9 AKADEUM LIFE SCIENCES 502 17.2.10 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG 503 17.2.11 INVENT BIOTECHNOLOGIES, INC. 504 18 RESEARCH METHODOLOGY 505 18.1 RESEARCH DATA 505 18.1.1 SECONDARY DATA 505 18.1.1.1 Key data from secondary sources 505 18.1.2 PRIMARY DATA 506 18.1.2.1 Key data from primary sources 506 18.1.2.2 Key primary participants 506 18.1.2.3 Breakdown of primary interviews 507 18.1.2.4 Key industry insights 508 18.2 MARKET SIZE ESTIMATION 509 18.2.1 GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025 509 18.2.2 SEGMENTAL MARKET SIZE ESTIMATION 511 18.3 MARKET GROWTH RATE PROJECTIONS 513 18.4 DATA TRIANGULATION 514 18.5 FACTOR ANALYSIS 515 18.6 RESEARCH ASSUMPTIONS 515 18.7 RESEARCH LIMITATIONS & RISK ASSESSMENT 516 19 APPENDIX 517 19.1 DISCUSSION GUIDE 517 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 521 19.3 CUSTOMIZATION OPTIONS 523 19.4 RELATED REPORTS 523 19.5 AUTHOR DETAILS 524
圖表清單 List of Tables & Figures
TABLE 1 CELL ISOLATION MARKET: INCLUSIONS & EXCLUSIONS 48 TABLE 2 CELL ISOLATION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 60 TABLE 3 CELL ISOLATION MARKET: PORTER’S FIVE FORCES 68 TABLE 4 CELL ISOLATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM 75 TABLE 5 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023–2025 (USD) 76 TABLE 6 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023–2025 (USD) 77 TABLE 7 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023–2025 (USD) 78 TABLE 8 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023–2025 (USD) 78 TABLE 9 IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 80 TABLE 10 EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 80 TABLE 11 CELL ISOLATION MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027 81 TABLE 12 RECIPROCAL TARIFF RATES ADJUSTED BY US 85 TABLE 13 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 87 TABLE 14 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025 94 TABLE 15 LIST OF KEY PATENTS IN CELL ISOLATION MARKET, 2023–2025 95 TABLE 16 CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET 99 TABLE 17 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES IN CELL ISOLATION MARKET 100 TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 103 TABLE 19 KEY BUYING CRITERIA, BY END USER 103 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107 TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 TABLE 24 CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 116 TABLE 25 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 117 TABLE 26 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 27 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 28 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 29 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 30 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 119 TABLE 31 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 32 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 120 TABLE 33 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024–2031 (USD MILLION) 121 TABLE 34 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 35 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 36 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 37 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 38 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024–2031 (USD MILLION) 123 TABLE 39 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 40 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 41 CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 124 TABLE 42 NORTH AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 43 EUROPE: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 44 ASIA PACIFIC: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 45 LATIN AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 46 MIDDLE EAST: CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 127 TABLE 47 GCC COUNTRIES: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 48 TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 128 TABLE 49 NORTH AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 50 EUROPE: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 51 ASIA PACIFIC: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 52 LATIN AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 53 MIDDLE EAST: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 130 TABLE 54 GCC COUNTRIES: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 55 OTHER REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 131 TABLE 56 NORTH AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 57 EUROPE: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 58 ASIA PACIFIC: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 59 LATIN AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 60 MIDDLE EAST: OTHER REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 61 GCC COUNTRIES: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 62 CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 63 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 64 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 65 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 66 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 67 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 68 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 69 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 70 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 71 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 72 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 73 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 74 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 75 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 76 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION) 141 TABLE 77 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 78 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 79 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 80 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 81 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 82 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 83 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 145 TABLE 84 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 85 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 86 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 87 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 88 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 89 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 90 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 91 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 92 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 93 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 94 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 95 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 96 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 97 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 98 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 99 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 100 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 101 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 102 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 103 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 104 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 105 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 106 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 107 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 108 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 109 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 110 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 111 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 112 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 113 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 114 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 115 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 116 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 117 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 118 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 119 OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 120 NORTH AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 121 EUROPE: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 122 ASIA PACIFIC: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 123 LATIN AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 124 MIDDLE EAST: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 125 GCC COUNTRIES: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 126 CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 167 TABLE 127 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024–2031 (USD MILLION) 168 TABLE 128 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 129 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 130 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 131 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 132 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 133 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 134 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 135 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 136 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 137 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 138 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 139 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 140 MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 141 GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 142 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 143 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 144 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 145 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 146 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 147 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 148 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 149 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 150 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 151 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 152 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 153 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 154 MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 155 GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 156 CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 183 TABLE 157 CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 158 NORTH AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 159 EUROPE: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 160 ASIA PACIFIC: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 161 LATIN AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 162 MIDDLE EAST: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 163 GCC COUNTRIES: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 164 CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024–2031 (USD MILLION) 187 TABLE 165 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 166 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 167 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 168 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 169 MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024–2031 (USD MILLION) 190 TABLE 170 GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 171 CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 172 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 173 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 174 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 175 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 176 MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 177 GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 178 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 179 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 180 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 181 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 182 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 183 MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024–2031 (USD MILLION) 197 TABLE 184 GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 185 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 186 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 187 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 188 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 189 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 190 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024–2031 (USD MILLION) 200 TABLE 191 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 192 CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 202 TABLE 193 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 194 NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 195 EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 196 ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 197 LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 198 MIDDLE EAST: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 199 GCC COUNTRIES: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 200 SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 201 NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 202 EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 203 ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 204 LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 205 MIDDLE EAST: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 209 TABLE 206 GCC COUNTRIES: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 207 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 208 NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 209 EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 210 ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 211 LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 212 MIDDLE EAST: FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 212 TABLE 213 GCC COUNTRIES: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 214 MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 215 NORTH AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 216 EUROPE: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 217 ASIA PACIFIC: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 218 LATIN AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 219 MIDDLE EAST: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 220 GCC COUNTRIES: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 221 CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 217 TABLE 222 CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 218 TABLE 223 NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 224 EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 225 ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 226 LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 227 MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 220 TABLE 228 GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 229 CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 230 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024–2031 (USD MILLION) 222 TABLE 231 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 232 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 233 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 234 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 235 MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024–2031 (USD MILLION) 224 TABLE 236 GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 237 CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 238 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 239 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 240 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 241 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 242 MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 243 GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 244 CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 245 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 246 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 247 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 248 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 249 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024–2031 (USD MILLION) 231 TABLE 250 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 251 CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION) 232 TABLE 252 NORTH AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 253 EUROPE: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 254 ASIA PACIFIC: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 255 LATIN AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 256 MIDDLE EAST: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 257 GCC COUNTRIES: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 258 CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 236 TABLE 259 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 260 EUROPE: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 261 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 262 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 263 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 238 TABLE 264 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 265 CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 239 TABLE 266 NORTH AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 267 EUROPE: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 268 ASIA PACIFIC: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 269 LATIN AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 270 MIDDLE EAST: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 242 TABLE 271 GCC COUNTRIES: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 272 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION) 243 TABLE 273 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 274 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 275 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 276 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 277 MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION) 245 TABLE 278 GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 279 CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 280 NORTH AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 281 EUROPE: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 282 ASIA PACIFIC: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 283 LATIN AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 284 MIDDLE EAST: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 285 GCC COUNTRIES: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 286 CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 251 TABLE 287 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 252 TABLE 288 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 289 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 290 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 291 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 254 TABLE 292 MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 254 TABLE 293 GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 254 TABLE 294 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 255 TABLE 295 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 296 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 297 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 298 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 299 MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 258 TABLE 300 GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 301 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 259 TABLE 302 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 303 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 304 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 305 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 306 MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 261 TABLE 307 GCC COUNTRIES: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 308 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 262 TABLE 309 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 310 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 311 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 312 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 313 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 264 TABLE 314 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 315 CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 266 TABLE 316 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 317 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 268 TABLE 318 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 319 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 320 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 321 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 269 TABLE 322 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 323 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 270 TABLE 324 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 270 TABLE 325 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 271 TABLE 326 NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 327 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 272 TABLE 328 US: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 272 TABLE 329 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 330 US: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 331 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 332 US: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 274 TABLE 333 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 334 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 274 TABLE 335 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 275 TABLE 336 US: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 275 TABLE 337 US: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 338 US: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 276 TABLE 339 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 277 TABLE 340 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 341 CANADA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 342 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 343 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 278 TABLE 344 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 345 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 279 TABLE 346 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 279 TABLE 347 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 280 TABLE 348 CANADA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 349 CANADA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 281 TABLE 350 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 351 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 282 TABLE 352 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 353 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 354 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 355 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 283 TABLE 356 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 357 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 284 TABLE 358 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 284 TABLE 359 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 285 TABLE 360 EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 361 EUROPE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 286 TABLE 362 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 287 TABLE 363 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 364 GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 365 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 366 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 288 TABLE 367 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 368 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 289 TABLE 369 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 289 TABLE 370 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 290 TABLE 371 GERMANY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 372 GERMANY: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 291 TABLE 373 UK: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 292 TABLE 374 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 375 UK: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 376 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 377 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 293 TABLE 378 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 379 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 294 TABLE 380 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 294 TABLE 381 UK: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 295 TABLE 382 UK: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 383 UK: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 296 TABLE 384 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 297 TABLE 385 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 386 FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 387 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 388 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 298 TABLE 389 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 390 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 299 TABLE 391 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 299 TABLE 392 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 300 TABLE 393 FRANCE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 394 FRANCE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 301 TABLE 395 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 302 TABLE 396 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 397 ITALY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 398 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 399 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 303 TABLE 400 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 401 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 304 TABLE 402 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 304 TABLE 403 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 305 TABLE 404 ITALY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 405 ITALY: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 306 TABLE 406 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 307 TABLE 407 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 408 SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 409 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 410 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 308 TABLE 411 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 412 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 309 TABLE 413 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 309 TABLE 414 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 310 TABLE 415 SPAIN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 416 SPAIN: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 311 TABLE 417 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 312 TABLE 418 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 419 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 420 REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 421 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 313 TABLE 422 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 423 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 314 TABLE 424 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 314 TABLE 425 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 315 TABLE 426 REST OF EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 427 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 316 TABLE 428 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 429 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 318 TABLE 430 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 431 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 432 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 433 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 319 TABLE 434 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 435 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 320 TABLE 436 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 320 TABLE 437 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 321 TABLE 438 ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 439 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 322 TABLE 440 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 323 TABLE 441 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 442 CHINA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 443 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 444 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 324 TABLE 445 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 446 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 325 TABLE 447 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 325 TABLE 448 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 326 TABLE 449 CHINA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 450 CHINA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 327 TABLE 451 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 328 TABLE 452 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 453 JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 454 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 455 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 329 TABLE 456 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 457 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 330 TABLE 458 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 330 TABLE 459 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 331 TABLE 460 JAPAN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 461 JAPAN: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 332 TABLE 462 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 333 TABLE 463 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 464 INDIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 465 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 466 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 334 TABLE 467 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 468 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 335 TABLE 469 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 335 TABLE 470 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 336 TABLE 471 INDIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 472 INDIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 337 TABLE 473 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 338 TABLE 474 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 475 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 476 AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 477 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 339 TABLE 478 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 479 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 340 TABLE 480 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 340 TABLE 481 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 341 TABLE 482 AUSTRALIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 341 TABLE 483 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 342 TABLE 484 SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 343 TABLE 485 SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 486 SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 487 SOUTH KOREA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 488 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 344 TABLE 489 SOUTH KOREA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 490 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 345 TABLE 491 SOUTH KOREA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 345 TABLE 492 SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 346 TABLE 493 SOUTH KOREA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 494 SOUTH KOREA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 347 TABLE 495 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 347 TABLE 496 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 497 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 498 REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 499 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 349 TABLE 500 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 501 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 350 TABLE 502 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 350 TABLE 503 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 351 TABLE 504 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 505 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 352 TABLE 506 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 353 TABLE 507 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 353 TABLE 508 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 509 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 510 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 511 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 354 TABLE 512 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 513 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 355 TABLE 514 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 356 TABLE 515 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 356 TABLE 516 LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 357 TABLE 517 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 357 TABLE 518 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 358 TABLE 519 BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 520 BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 521 BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 522 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 359 TABLE 523 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 524 BRAZIL: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 360 TABLE 525 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 361 TABLE 526 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 361 TABLE 527 BRAZIL: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 528 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 362 TABLE 529 MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 363 TABLE 530 MEXICO: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 531 MEXICO: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 532 MEXICO: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 533 MEXICO: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 364 TABLE 534 MEXICO: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 535 MEXICO: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 365 TABLE 536 MEXICO: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 366 TABLE 537 MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 366 TABLE 538 MEXICO: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 539 MEXICO: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 367 TABLE 540 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 368 TABLE 541 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 542 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 543 REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 544 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 370 TABLE 545 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 546 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 370 TABLE 547 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 371 TABLE 548 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 371 TABLE 549 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 372 TABLE 550 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 372 TABLE 551 MIDDLE EAST: CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION) 373 TABLE 552 MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 373 TABLE 553 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 554 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 555 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 556 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 375 TABLE 557 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 558 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 376 TABLE 559 MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 376 TABLE 560 MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 377 TABLE 561 MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 562 MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 378 TABLE 563 GCC COUNTRIES: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 378 TABLE 564 GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 379 TABLE 565 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 566 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 567 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 568 GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 380 TABLE 569 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 570 GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 381 TABLE 571 GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 381 TABLE 572 GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 382 TABLE 573 GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 574 GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 383 TABLE 575 SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 384 TABLE 576 SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 577 SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 578 SAUDI ARABIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 579 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 385 TABLE 580 SAUDI ARABIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 581 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 386 TABLE 582 SAUDI ARABIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 386 TABLE 583 SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 387 TABLE 584 SAUDI ARABIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 585 SAUDI ARABIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 388 TABLE 586 UAE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 389 TABLE 587 UAE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 588 UAE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 589 UAE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 590 UAE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 390 TABLE 591 UAE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 592 UAE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 391 TABLE 593 UAE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 391 TABLE 594 UAE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392 TABLE 595 UAE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 596 UAE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 393 TABLE 597 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 393 TABLE 598 REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 599 REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 600 REST OF GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 601 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 395 TABLE 602 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 603 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 396 TABLE 604 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 396 TABLE 605 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 397 TABLE 606 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 607 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 398 TABLE 608 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 398 TABLE 609 REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 610 REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 611 REST OF MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 612 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 400 TABLE 613 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 614 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 401 TABLE 615 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 401 TABLE 616 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 402 TABLE 617 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 618 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 403 TABLE 619 AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 403 TABLE 620 AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 621 AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 622 AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 623 AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION) 405 TABLE 624 AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 625 AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION) 406 TABLE 626 AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION) 406 TABLE 627 AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 407 TABLE 628 AFRICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 629 AFRICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION) 408 TABLE 630 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023–APRIL 2026 409 TABLE 631 CELL ISOLATION MARKET: DEGREE OF COMPETITION 412 TABLE 632 CELL ISOLATION MARKET: REGION FOOTPRINT 417 TABLE 633 CELL ISOLATION MARKET: PRODUCT FOOTPRINT 418 TABLE 634 CELL ISOLATION MARKET: CELL TYPE FOOTPRINT 419 TABLE 635 CELL ISOLATION MARKET: END-USER FOOTPRINT 420 TABLE 636 CELL ISOLATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 423 TABLE 637 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 424 TABLE 638 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 427 TABLE 639 CELL ISOLATION MARKET: DEALS, JANUARY 2023–APRIL 2026 428 TABLE 640 CELL ISOLATION MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026 429 TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW 430 TABLE 642 DANAHER CORPORATION: PRODUCTS OFFERED 431 TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026 432 TABLE 644 MERCK KGAA: COMPANY OVERVIEW 434 TABLE 645 MERCK KGAA: PRODUCTS OFFERED 435 TABLE 646 MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026 436 TABLE 647 MERCK KGAA: EXPANSIONS, JANUARY 2023–APRIL 2026 436 TABLE 648 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 438 TABLE 649 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 439 TABLE 650 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 443 TABLE 651 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026 444 TABLE 652 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026 445 TABLE 653 BD: COMPANY OVERVIEW 447 TABLE 654 BD: PRODUCTS OFFERED 448 TABLE 655 BD: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 451 TABLE 656 BD: DEALS, JANUARY 2023–APRIL 2026 451 TABLE 657 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 453 TABLE 658 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 454 TABLE 659 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026 455 TABLE 660 SARTORIUS AG: COMPANY OVERVIEW 456 TABLE 661 SARTORIUS AG: PRODUCTS OFFERED 457 TABLE 662 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 459 TABLE 663 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 460 TABLE 664 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 461 TABLE 665 QIAGEN: COMPANY OVERVIEW 462 TABLE 666 QIAGEN: PRODUCTS OFFERED 463 TABLE 667 QIAGEN: DEALS, JANUARY 2023–APRIL 2026 464 TABLE 668 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 465 TABLE 669 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 466 TABLE 670 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2023–APRIL 2026 467 TABLE 671 REVVITY: COMPANY OVERVIEW 468 TABLE 672 REVVITY: PRODUCTS OFFERED 469 TABLE 673 CORNING INCORPORATED: COMPANY OVERVIEW 472 TABLE 674 CORNING INCORPORATED: PRODUCTS OFFERED 473 TABLE 675 LONZA: COMPANY OVERVIEW 475 TABLE 676 LONZA: PRODUCTS OFFERED 476 TABLE 677 BIO-TECHNE: COMPANY OVERVIEW 477 TABLE 678 BIO-TECHNE: PRODUCTS OFFERED 478 TABLE 679 TERUMO CORPORATION: COMPANY OVERVIEW 480 TABLE 680 TERUMO CORPORATION: PRODUCTS OFFERED 481 TABLE 681 MILTENYI BIOTEC: COMPANY OVERVIEW 482 TABLE 682 MILTENYI BIOTEC: PRODUCTS OFFERED 482 TABLE 683 TAKARA BIO INC.: COMPANY OVERVIEW 484 TABLE 684 TAKARA BIO INC.: PRODUCTS OFFERED 485 TABLE 685 GENSCRIPT: COMPANY OVERVIEW 487 TABLE 686 GENSCRIPT: PRODUCTS OFFERED 488 TABLE 687 GENSCRIPT: DEALS, JANUARY 2023–APRIL 2026 489 TABLE 688 SONY CORPORATION: COMPANY OVERVIEW 490 TABLE 689 SONY CORPORATION: PRODUCTS OFFERED 491 TABLE 690 ALFA LAVAL: COMPANY OVERVIEW 492 TABLE 691 ALFA LAVAL: PRODUCTS OFFERED 493 TABLE 692 ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 494 TABLE 693 ALFA LAVAL: DEALS, JANUARY 2023–APRIL 2026 495 TABLE 694 PROMEGA CORPORATION: COMPANY OVERVIEW 496 TABLE 695 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW 497 TABLE 696 MICAREO INC.: COMPANY OVERVIEW 497 TABLE 697 APPLIED CELLS, INC.: COMPANY OVERVIEW 498 TABLE 698 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW 499 TABLE 699 CREATIVE BIOARRAY: COMPANY OVERVIEW 500 TABLE 700 PROTEINTECH GROUP, INC.: COMPANY OVERVIEW 500 TABLE 701 MAGBIO GENOMICS, INC.: COMPANY OVERVIEW 501 TABLE 702 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW 502 TABLE 703 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG: COMPANY OVERVIEW 503 TABLE 704 INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW 504 TABLE 705 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 515 TABLE 706 RISK ASSESSMENT 516 FIGURE 1 CELL ISOLATION MARKET SEGMENTATION & REGIONS CONSIDERED 47 FIGURE 2 CELL ISOLATION MARKET: YEARS CONSIDERED 49 FIGURE 3 MARKET SCENARIO 51 FIGURE 4 GLOBAL CELL ISOLATION MARKET, 2024–2031 52 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, 2023–2026 52 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF CELL ISOLATION MARKET 53 FIGURE 7 HIGH-GROWTH SEGMENTS IN CELL ISOLATION MARKET, 2026–2031 54 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN CELL ISOLATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 55 FIGURE 9 RISING ADOPTION OF STEM CELL RESEARCH AND IMMUNOLOGY RESEARCH TO DRIVE MARKET GROWTH 56 FIGURE 10 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF CELL ISOLATION MARKET IN NORTH AMERICA IN 2025 57 FIGURE 11 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL CELL ISOLATION MARKET DURING FORECAST PERIOD 58 FIGURE 12 CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD 58 FIGURE 13 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60 FIGURE 14 CELL ISOLATION MARKET: PORTER’S FIVE FORCES ANALYSIS 69 FIGURE 15 CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS 72 FIGURE 16 CELL ISOLATION MARKET: ECOSYSTEM ANALYSIS 74 FIGURE 17 AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY KEY PLAYER, 2025 (USD) 76 FIGURE 18 AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY KEY PLAYER, 2025 (USD) 77 FIGURE 19 AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY REGION, 2025 (USD) 78 FIGURE 20 AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY REGION, 2025 (USD) 79 FIGURE 21 CELL ISOLATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 FIGURE 22 INVESTMENT & FUNDING SCENARIO, 2023–2025 (USD MILLION) 84 FIGURE 23 PATENT APPLICATIONS IN CELL ISOLATION MARKET, JANUARY 2015–DECEMBER 2025 95 FIGURE 24 IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET 98 FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 102 FIGURE 26 KEY BUYING CRITERIA, BY END USER 103 FIGURE 27 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT 267 FIGURE 28 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT 317 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2021–2025 (USD MILLION) 411 FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2025 412 FIGURE 31 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 415 FIGURE 32 CELL ISOLATION MARKET: COMPANY FOOTPRINT 416 FIGURE 33 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 422 FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 425 FIGURE 35 EV/EBITDA OF KEY VENDORS 425 FIGURE 36 CELL ISOLATION MARKET: BRAND COMPARISON 426 FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 431 FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2025) 435 FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 439 FIGURE 40 BD: COMPANY SNAPSHOT (2025) 448 FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 454 FIGURE 42 SARTORIUS AG: COMPANY SNAPSHOT (2025) 457 FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 460 FIGURE 44 QIAGEN: COMPANY SNAPSHOT (2025) 463 FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 466 FIGURE 46 REVVITY: COMPANY SNAPSHOT (2025) 469 FIGURE 47 CORNING INCORPORATED: COMPANY SNAPSHOT (2025) 473 FIGURE 48 LONZA: COMPANY SNAPSHOT (2025) 476 FIGURE 49 BIO-TECHNE: COMPANY SNAPSHOT (2025) 478 FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2024) 481 FIGURE 51 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 485 FIGURE 52 GENSCRIPT: COMPANY SNAPSHOT (2025) 487 FIGURE 53 SONY CORPORATION: COMPANY SNAPSHOT (2024) 491 FIGURE 54 ALFA LAVAL: COMPANY SNAPSHOT (2025) 493 FIGURE 55 CELL ISOLATION MARKET: RESEARCH DESIGN 505 FIGURE 56 CELL ISOLATION MARKET: BREAKDOWN OF PRIMARIES 507 FIGURE 57 CELL ISOLATION MARKET: INSIGHTS FROM PRIMARIES 508 FIGURE 58 GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025 509 FIGURE 59 CELL ISOLATION MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025) 510 FIGURE 60 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE ANALYSIS (2025) 510 FIGURE 61 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 511 FIGURE 62 CELL ISOLATION MARKET: CAGR PROJECTIONS 513 FIGURE 63 CELL ISOLATION MARKET: DATA TRIANGULATION 514

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們